Showing 4361-4370 of 7009 results for "".
- Breakthrough Dual-action mRNA Vaccine Targets Merkel Cell Carcinomahttps://reachmd.com/news/breakthrough-dual-action-mrna-vaccine-targets-merkel-cell-carcinoma/2484321/Yale researchers have developed a dual-action mRNA vaccine that tar
- Addressing the Menopause Care Gap: Key Findings on Barriers and Opportunitieshttps://reachmd.com/news/addressing-the-menopause-care-gap-key-findings-on-barriers-and-opportunities/2484288/A Mayo Clinic survey of nearly 5,000 women aged 45-60 in primary care found that 34% reported moderate‑to‑very‑severe menopause symptoms, yet most did not see
- Improving Fertility Preservation Decisions in Cancer Patients: Insights from Hormonal Biomarkershttps://reachmd.com/news/improving-fertility-preservation-decisions-in-cancer-patients-insights-from-hormonal-biomarkers/2484272/A recent study in Frontiers in Oncology reports associations between baseline anti-Mullerian hormone (AMH) and oocyte yield as well as subse
- Implications of Prolonged PSA Screening on Prostate Cancer Outcomes: Insights from the ERSPChttps://reachmd.com/news/implications-of-prolonged-psa-screening-on-prostate-cancer-outcomes-insights-from-the-erspc/2484266/In a 23-year follow-up study published in The New England Journal of Medicine, organized PSA screening produced a 13% relative reduction in prostate cancer mortality (1.4% in
- Tapinarof Sustains AD Remission for 75+ Days Post-Treatmenthttps://reachmd.com/news/tapinarof-sustains-ad-remission-for-75-days-post-treatment/2484253/New long-term data from the ADORING 3 trial show that tapinarof cream 1% (VTAMA, Organon), a non-steroidal topical aryl hydrocarbon receptor agonist, can sustain low disease activity and pruritus in patients with atopic dermatitis (AD), including children as young
- Upadacitinib Demonstrates Rapid Improvement in AD Patients With Prurigo Noduleshttps://reachmd.com/news/upadacitinib-demonstrates-rapid-improvement-in-ad-patients-with-prurigo-nodules/2484113/A new interim analysis from the ADMIRE study, presented at the 2025 Fall Clinical Dermatology Conference, reported that upadacitinib yields rapid and sustained improvements in patients with moderate-to-severe atopic dermatitis (AD) complicated by prurigo nodules, o
- Allergan Aesthetics Awards $400K in Grants to Women Entrepreneurs Through the Confidence Projecthttps://reachmd.com/news/allergan-aesthetics-awards-400k-in-grants-to-women-entrepreneurs-through-the-confidence-project/2484037/Allergan Aesthetics, an AbbVie company, announced the 20 recipients of this year’s Confidence Project: Empowering Women Entrepreneurs grants. Each participant completed a 12-week Boostcamp and pitched their business to a panel of aesthetic entrepreneurs and Allerga
- Pandemic Effects: Vitamin D Decline and Its Clinical Implicationshttps://reachmd.com/news/pandemic-effects-vitamin-d-decline-and-its-clinical-implications/2484021/Routine laboratory data demonstrate a measurable decline in population 25-hydroxyvitamin D during the COVID-19 pandemic, with the largest drops in elderly women, young adults, and urban residents, according to a
- Regionwide Mental Health Week Launches with Focus on Children, Connection, and Community-Based Carehttps://reachmd.com/news/regionwide-mental-health-week-launches-with-focus-on-children-connection-and-community-based-care/2483922/PAHO and the OAS have launched the first Inter‑American Mental Health Week—"Empower, Connect, Care"—spotlighting child and youth mental health and regionwide capacity building. Regionally coordinated activities provide immediate tools for primary care and school syst
- Dr. Andrew Alexis Highlights 2-MNG as Option to Treat Acne-Related PIHhttps://reachmd.com/news/dr-andrew-alexis-highlights-2-mng-as-option-to-treat-acne-related-pih/2483902/The topical agent 2-Mercaptonicotinoyl glycine (2-MNG), also marketed as Melasyl, could be key to treating acne-related postinflammatory hyperpigmentation (PIH) in skin of color, Andrew Alexis, MD, MPH, said at the Skin of Color Update in New York, New York. Dr. Alexis presented on managin